The patient has participated in a comprehensive weight management program for at least 6 months that includes behavioral modification, dietary changes, physical activity, and ongoing follow-up, and
The original GLP-1 trials paired pharmacotherapy with structured lifestyle support
Transparency: Clinics should disclose sourcing, quality assurance, and potential risks
10.3390/ijms232315330 47
7), we now quantified NONO/SFPQ already at a lower ASO concentration (15 nM), but, again, their enrichment factors increased steadily when increasing the ASO dose (Fig
The second antibody was a biotinylated goat anti-rabbit immunoglobulin, and the signal was detected using the Vectastain ABC kit (Vector Laboratories, Burlingame, California, USA) with DAB as a substrate